Jason Luke
University of Pittsburgh Medical Center

Last Updated On 10/23/2020 1:57:46 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Actym Therapeutics
Recipient: You
Company: Mavu Pharmaceutical
Recipient: You
Company: Pyxis
Recipient: You
Company: Alphamab Oncology
Recipient: You
Company: Tempest Therapeutics
Recipient: You
Company: Kanaph Therapeutics
Recipient: You
Company: Onc.AI
Recipient: You
Company: Arch Oncology
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Array BioPharma
Recipient: You
Company: Bristol-Myers Squibb
Recipient: You
Company: Merck
Recipient: You
Company: EMD Serono
Recipient: You
Company: Novartis
Recipient: You
Company: 7 Hills Pharma
Recipient: You
Company: Janssen
Recipient: You
Company: Reflexion Medical
Recipient: You
Company: Tempest Therapeutics
Recipient: You
Company: TTC Oncology
Recipient: You
Company: Alphamab Oncology
Recipient: You
Company: Compugen
Recipient: You
Company: Spring Bank
Recipient: You
Company: Abbvie
Recipient: You
Company: Astellas Pharma
Recipient: You
Company: Bayer
Recipient: You
Company: Incyte
Recipient: You
Company: Mersana
Recipient: You
Company: Partner Therapeutics
Recipient: You
Company: Synlogic
Recipient: You
Company: Eisai
Recipient: You
Company: Werewolf
Recipient: You
Company: Ribon Therapeutics
Recipient: You
Company: Checkmate Pharmaceuticals
Recipient: You
Company: CStone Pharmaceuticals
Recipient: You
Company: Nektar
Recipient: You
Company: Regeneron
Recipient: You
Company: Rubius
Recipient: You
Company: Tesaro
Recipient: You
Company: Xilio
Recipient: You
Company: Xencor
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Checkmate Pharmaceuticals
Recipient: You
Company: Array BioPharma
Recipient: You
Company: Agios
Recipient: You
Company: Astellas Pharma
Recipient: You
Company: EMD Serono
Recipient: You
Company: Immatics
Recipient: You
Company: Kadmon
Recipient: You
Company: Moderna Therapeutics
Recipient: You
Company: Nektar
Recipient: You
Company: Spring bank
Recipient: You
Company: Trishula
Recipient: You
Company: Merck
Recipient: Your Institution
Company: Bristol-Myers Squibb
Recipient: Your Institution
Company: Incyte
Recipient: Your Institution
Company: Corvus Pharmaceuticals
Recipient: Your Institution
Company: Abbvie
Recipient: Your Institution
Company: Macrogenics
Recipient: Your Institution
Company: Xencor
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: Serial #15/612,657 (Cancer Immunotherapy),
Recipient: You
Please describe: Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
Company: Bristol-Myers Squibb
Recipient: You
Company: Array BioPharma
Recipient: You
Company: EMD Serono
Recipient: You
Company: Janssen
Recipient: You
Company: Merck
Recipient: You
Company: Novartis
Recipient: You
Company: Reflexion Medical
Recipient: You
Company: Mersana
Recipient: You
Company: Pyxis
Recipient: You
Company: Xilio
Recipient: You

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered